Invitrogen™ Human LZTR1 Synthetic Peptide

Catalog No.	Quantity
PEP1016	50 μg

Catalog No. PEP1016 Supplier Invitrogen™ Supplier No. PEP1016

Description

Synthetic Peptide

LZTR1 Synthetic Peptide, PEP-1016, from Invitrogen.

LZTR1, a member of the BTB-kelch superfamily, was initially described as a putative transcriptional regulator based on weak homology to members of the basic leucine zipper-like family, the encoded protein subsequently has been shown to localize exclusively to the Golgi network where it may help stabilize the Golgi complex. Deletion of this gene may be associated with DiGeorge syndrome, a developmental field defect involving the third and fourth pharyngeal pouches, causing the absence of thymus and parathyroid glands, congenital cardiac abnormalities and facial dysmorphism. LZTR1 is tyrosine phosphorylated and subsequently degraded upon induction of apoptosis.

Specifications

• Gene ID (Entrez): 8216
• Species: Human
• Purification Method: purified
• Accession Number: Q8N653
• Common Name: Human LZTR1
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: LZTR1
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS